迪利普·马哈拉纳比斯博士 (1934-2022):腹疾病管理的开拓者
Umesh Kawalkar1, Amar Mankar2, Priti Kogade3
1Community Medicine, Government Medical College (GMC) Akola, Akola, IND.
Cureus
|July 15, 2024
概括
先进的儿科医生迪利普·马哈拉纳比斯 (Dilip Mahalanabis) 开发了口服补水疗法 (ORT),这是一种简单的治疗方法,可以大大减少因腹疾病和霍乱导致的死亡. 他的工作彻底改变了全球卫生状况,特别是在世界各地的弱势群体.
科学领域:
- 全球健康 全球健康
- 儿科 儿科 儿科
- 传染病控制和控制传染病
背景情况:
- 腹疾病,尤其是霍乱,在全球范围内造成了高死亡率.
- 获得有效治疗方法的限制加剧了危机,特别是在资源较少的环境中.
- 孟加拉国独立战争强调了急需提供可访问的医疗干预措施的迫切需要.
研究的目的:
- 介绍并详细介绍口腔补水疗法 (ORT) 的发展和影响.
- 突出迪利普·马哈拉纳比斯博士对全球公共卫生的贡献.
- 强调ORT在减少腹疾病死亡率方面的重要性.
主要方法:
- 开发一种低成本,易于注射的口服补水溶液.
- 实施和广泛推广口腔补水疗法 (ORT) 协议.
- 与国际卫生组织合作,以传播治疗.
主要成果:
- 霍乱和其他腹性疾病的死亡率显著降低.
- 通过一种简单,具有成本效益的治疗方法赋予社区权力.
- 建立ORT作为全球腹疾病管理的基石.
结论:
- 迪利普·马哈拉纳比斯博士在口腔补水疗法 (ORT) 的创新已经挽救了数百万人的生命.
- ORT代表了一项重大的公共卫生成就,民主化了基本医疗保健.
- 他的遗产强调了简单,易于获得的解决方案在应对全球卫生挑战的力量.
相关概念视频
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
115
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
115
Drugs for Treatment of Diarrhea-Predominant IBS
156
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
156
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Inflammatory Bowel Disease IV: Pharmacological Management
125
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
125
Inflammatory Bowel Disease V: Surgical Management
139
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
139
Inflammatory Bowel Disease I: Ulcerative Colitis
160
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
160


